Nkarta, Inc. (NKTX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$2.75−$0.1000 (−3.51%) on the dayAs of the close; data may be delayed.
NKTX price, last 12 months
Key stats
- Previous close
- $2.85
- Open
- $2.85
- Day range
- $2.73 – $2.90
- 52-week range
- $1.70 – $3.72
- Volume
- 617.8K
- Avg volume (20 days)
- 631.4K
- Market cap
- $197.0M
Performance
1W−2.8%
1M+4.6%
3M−2.8%
6M+28.5%
YTD+48.7%
1Y+33.5%
vs S&P 500, 1Y+16.7 pts
Technicals and fundamentals
About Nkarta, Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $197.0M